Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,075 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

A Study to Investigate the Relationship Between Duration of Treatment and Response in Patients With Multiple Myeloma (MM) or Systemic AL Amyloidosis Treated in Real-life Practice

NCT04659798

Conditions
Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +17 more
Locations
  • H. Puerta del Mar Cadiz, Andalusia, Spain
  • Hospital Regional Universitario de Malaga (Carlos de Haya) Málaga, Andalusia, Spain
  • H. Universitari Son Espases Palma de Mallorca, Balearic Islands, Spain
  • H. Universitario de Araba Vitoria-Gasteiz, Basque Country, Spain
View all 14 locations
View Trial Details
Completed

A Study Evaluating The Safety And Pharmacokinetics Of Escalating Doses Of RO7297089 In Patients With Relapsed Or Refractory Multiple Myeloma

NCT04434469

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
  • LIVERPOOL HOSPITAL; HAEMATOLOGY; Ingham Institute for Medical Research Liverpool, New South Wales, Australia
  • Royal Adelaide Hospital; Haematology Clinical Trials Adelaide, South Australia, Australia
  • St. Vincent's Hospital Melbourne Fitzroy, South Australia, Australia
View Trial Details
Completed

TJ202, Lenalidomide and Dexamethasone vs. Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

NCT03952091

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Capital Medical University (CMU) - Beijing Chao-Yang Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Capital Medical University (CMU) - Beijing Chao-Yang Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Bengbu Medical college Bengbu, China
View all 41 locations
View Trial Details
Completed

A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

NCT03439293

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Pacific Cancer Medical Center Anaheim, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • SCRI - Florida Cancer Specialists - Panhandle Tallahassee, Florida, United States
  • Research Medical Center - Kansas City Kansas City, Missouri, United States
View all 28 locations
View Trial Details
Completed

Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients

NCT03194867

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University of Colorado-Site Number:8400001 Denver, Colorado, United States
  • University of Kansas Medical Center-Site Number:8400003 Kansas City, Kansas, United States
  • Memorial Sloan-Kettering Cancer Center-Site Number:8400002 New York, United States
  • Fox Chase Cancer Center-Site Number:8400004 Philadelphia, Pennsylvania, United States
View all 30 locations
View Trial Details
Completed

Study of ISB 1342, a CD38/CD3 Bispecific Antibody, in Subjects With Previously Treated Multiple Myeloma

NCT03309111

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Johns Hopkins Medicine - The Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Mayo Clinic Cancer Center (MCCC) - Rochester Rochester, Minnesota, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View all 20 locations
View Trial Details

Related conditions